Cargando…
A better overall survival (OS) for total (ipsilateral) retroperitoneal lipectomy than standard complete resection in patients with retroperitoneal liposarcoma: a comparative multi-institutional study
BACKGROUND: Complete resection (CR) serves as the standard of surgical treatment for retroperitoneal liposarcoma (RPLS). Unfortunately, even at referral centers, recurrence rates are high, and CR may not address multifocal diseases, which are a common phenomenon in RPLS. We sought to retrospectively...
Autores principales: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9372660/ https://www.ncbi.nlm.nih.gov/pubmed/35965811 http://dx.doi.org/10.21037/atm-22-3332 |
_version_ | 1784767435451138048 |
---|---|
author | Miao, Cheng-Li Zhang, Ling-Ling Tseng, William W. Qiu, Fa-Bo Lu, Wei-Qi Dai, You-Guo Rao, Xiao-Song Li, Wen-Jie Zhang, Gao-Kui Chen, Jun Liu, Wen-Qing Chen, Xiao-Bing Xiao, Meng-Meng Cha, Li-Chao Wang, Jiong-Yuan Ren, Yu-Bo Yang, Hao-Yun Luo, Cheng-Hua |
author_facet | Miao, Cheng-Li Zhang, Ling-Ling Tseng, William W. Qiu, Fa-Bo Lu, Wei-Qi Dai, You-Guo Rao, Xiao-Song Li, Wen-Jie Zhang, Gao-Kui Chen, Jun Liu, Wen-Qing Chen, Xiao-Bing Xiao, Meng-Meng Cha, Li-Chao Wang, Jiong-Yuan Ren, Yu-Bo Yang, Hao-Yun Luo, Cheng-Hua |
author_sort | Miao, Cheng-Li |
collection | PubMed |
description | BACKGROUND: Complete resection (CR) serves as the standard of surgical treatment for retroperitoneal liposarcoma (RPLS). Unfortunately, even at referral centers, recurrence rates are high, and CR may not address multifocal diseases, which are a common phenomenon in RPLS. We sought to retrospectively compare the clinical outcomes of RPLS patients treated with total (ipsilateral) retroperitoneal lipectomy (TRL) and CR. Because TRL remove potentially multifocal tumors in the fat, patients may have a better prognosis than CR. METHODS: Patients with primary/first-recurrent RPLS who had been treated at 5 referral centers were recruited from December 2014 to June 2018. Multivariable Cox regression analyses were conducted to determine the effects of demographic, operative, and clinicopathological variables on the following primary endpoints: local recurrence (LR), local recurrence-free survival (LRFS), and overall survival (OS). RESULTS: A total of 134 patients were enrolled in this retrospective study, 53 of whom underwent TRL, and 81 of whom underwent CR. The 2 groups were comparable in terms of age, gender, presentation (primary vs. first-recurrent RPLS), number of tumors (unifocal vs. multifocal) at presentation, and Fédération Nationale des Centres de Lutte Contre le Cancer (FNCLCC) grade. The TRL group had higher levels of preoperative hemoglobin (Hb) (13 vs. 12.5 g/dL; P=0.008) and a lower amount of intraoperative blood loss (400 vs. 500 mL; P=0.034), but there were no significant differences in the length of hospital stay (23 vs. 22 d; P=0.47) or complications (32 vs. 30; P=0.82) between the 2 groups. In a subset of patients with multifocal tumors at initial presentation, OS was more prolonged in those treated with TRL than those treated with CR (P=0.0272). Based on the multivariable analysis, primary liposarcoma and a low FNCLCC grade were associated with decreased LR and improved OS. CONCLUSIONS: TRL is a safe procedure that positively affects the OS of patients with multifocal RPLS. This novel strategy deserves further investigation in prospective studies. |
format | Online Article Text |
id | pubmed-9372660 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | AME Publishing Company |
record_format | MEDLINE/PubMed |
spelling | pubmed-93726602022-08-13 A better overall survival (OS) for total (ipsilateral) retroperitoneal lipectomy than standard complete resection in patients with retroperitoneal liposarcoma: a comparative multi-institutional study Miao, Cheng-Li Zhang, Ling-Ling Tseng, William W. Qiu, Fa-Bo Lu, Wei-Qi Dai, You-Guo Rao, Xiao-Song Li, Wen-Jie Zhang, Gao-Kui Chen, Jun Liu, Wen-Qing Chen, Xiao-Bing Xiao, Meng-Meng Cha, Li-Chao Wang, Jiong-Yuan Ren, Yu-Bo Yang, Hao-Yun Luo, Cheng-Hua Ann Transl Med Original Article BACKGROUND: Complete resection (CR) serves as the standard of surgical treatment for retroperitoneal liposarcoma (RPLS). Unfortunately, even at referral centers, recurrence rates are high, and CR may not address multifocal diseases, which are a common phenomenon in RPLS. We sought to retrospectively compare the clinical outcomes of RPLS patients treated with total (ipsilateral) retroperitoneal lipectomy (TRL) and CR. Because TRL remove potentially multifocal tumors in the fat, patients may have a better prognosis than CR. METHODS: Patients with primary/first-recurrent RPLS who had been treated at 5 referral centers were recruited from December 2014 to June 2018. Multivariable Cox regression analyses were conducted to determine the effects of demographic, operative, and clinicopathological variables on the following primary endpoints: local recurrence (LR), local recurrence-free survival (LRFS), and overall survival (OS). RESULTS: A total of 134 patients were enrolled in this retrospective study, 53 of whom underwent TRL, and 81 of whom underwent CR. The 2 groups were comparable in terms of age, gender, presentation (primary vs. first-recurrent RPLS), number of tumors (unifocal vs. multifocal) at presentation, and Fédération Nationale des Centres de Lutte Contre le Cancer (FNCLCC) grade. The TRL group had higher levels of preoperative hemoglobin (Hb) (13 vs. 12.5 g/dL; P=0.008) and a lower amount of intraoperative blood loss (400 vs. 500 mL; P=0.034), but there were no significant differences in the length of hospital stay (23 vs. 22 d; P=0.47) or complications (32 vs. 30; P=0.82) between the 2 groups. In a subset of patients with multifocal tumors at initial presentation, OS was more prolonged in those treated with TRL than those treated with CR (P=0.0272). Based on the multivariable analysis, primary liposarcoma and a low FNCLCC grade were associated with decreased LR and improved OS. CONCLUSIONS: TRL is a safe procedure that positively affects the OS of patients with multifocal RPLS. This novel strategy deserves further investigation in prospective studies. AME Publishing Company 2022-07 /pmc/articles/PMC9372660/ /pubmed/35965811 http://dx.doi.org/10.21037/atm-22-3332 Text en 2022 Annals of Translational Medicine. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
spellingShingle | Original Article Miao, Cheng-Li Zhang, Ling-Ling Tseng, William W. Qiu, Fa-Bo Lu, Wei-Qi Dai, You-Guo Rao, Xiao-Song Li, Wen-Jie Zhang, Gao-Kui Chen, Jun Liu, Wen-Qing Chen, Xiao-Bing Xiao, Meng-Meng Cha, Li-Chao Wang, Jiong-Yuan Ren, Yu-Bo Yang, Hao-Yun Luo, Cheng-Hua A better overall survival (OS) for total (ipsilateral) retroperitoneal lipectomy than standard complete resection in patients with retroperitoneal liposarcoma: a comparative multi-institutional study |
title | A better overall survival (OS) for total (ipsilateral) retroperitoneal lipectomy than standard complete resection in patients with retroperitoneal liposarcoma: a comparative multi-institutional study |
title_full | A better overall survival (OS) for total (ipsilateral) retroperitoneal lipectomy than standard complete resection in patients with retroperitoneal liposarcoma: a comparative multi-institutional study |
title_fullStr | A better overall survival (OS) for total (ipsilateral) retroperitoneal lipectomy than standard complete resection in patients with retroperitoneal liposarcoma: a comparative multi-institutional study |
title_full_unstemmed | A better overall survival (OS) for total (ipsilateral) retroperitoneal lipectomy than standard complete resection in patients with retroperitoneal liposarcoma: a comparative multi-institutional study |
title_short | A better overall survival (OS) for total (ipsilateral) retroperitoneal lipectomy than standard complete resection in patients with retroperitoneal liposarcoma: a comparative multi-institutional study |
title_sort | better overall survival (os) for total (ipsilateral) retroperitoneal lipectomy than standard complete resection in patients with retroperitoneal liposarcoma: a comparative multi-institutional study |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9372660/ https://www.ncbi.nlm.nih.gov/pubmed/35965811 http://dx.doi.org/10.21037/atm-22-3332 |
work_keys_str_mv | AT miaochengli abetteroverallsurvivalosfortotalipsilateralretroperitoneallipectomythanstandardcompleteresectioninpatientswithretroperitonealliposarcomaacomparativemultiinstitutionalstudy AT zhanglingling abetteroverallsurvivalosfortotalipsilateralretroperitoneallipectomythanstandardcompleteresectioninpatientswithretroperitonealliposarcomaacomparativemultiinstitutionalstudy AT tsengwilliamw abetteroverallsurvivalosfortotalipsilateralretroperitoneallipectomythanstandardcompleteresectioninpatientswithretroperitonealliposarcomaacomparativemultiinstitutionalstudy AT qiufabo abetteroverallsurvivalosfortotalipsilateralretroperitoneallipectomythanstandardcompleteresectioninpatientswithretroperitonealliposarcomaacomparativemultiinstitutionalstudy AT luweiqi abetteroverallsurvivalosfortotalipsilateralretroperitoneallipectomythanstandardcompleteresectioninpatientswithretroperitonealliposarcomaacomparativemultiinstitutionalstudy AT daiyouguo abetteroverallsurvivalosfortotalipsilateralretroperitoneallipectomythanstandardcompleteresectioninpatientswithretroperitonealliposarcomaacomparativemultiinstitutionalstudy AT raoxiaosong abetteroverallsurvivalosfortotalipsilateralretroperitoneallipectomythanstandardcompleteresectioninpatientswithretroperitonealliposarcomaacomparativemultiinstitutionalstudy AT liwenjie abetteroverallsurvivalosfortotalipsilateralretroperitoneallipectomythanstandardcompleteresectioninpatientswithretroperitonealliposarcomaacomparativemultiinstitutionalstudy AT zhanggaokui abetteroverallsurvivalosfortotalipsilateralretroperitoneallipectomythanstandardcompleteresectioninpatientswithretroperitonealliposarcomaacomparativemultiinstitutionalstudy AT chenjun abetteroverallsurvivalosfortotalipsilateralretroperitoneallipectomythanstandardcompleteresectioninpatientswithretroperitonealliposarcomaacomparativemultiinstitutionalstudy AT liuwenqing abetteroverallsurvivalosfortotalipsilateralretroperitoneallipectomythanstandardcompleteresectioninpatientswithretroperitonealliposarcomaacomparativemultiinstitutionalstudy AT chenxiaobing abetteroverallsurvivalosfortotalipsilateralretroperitoneallipectomythanstandardcompleteresectioninpatientswithretroperitonealliposarcomaacomparativemultiinstitutionalstudy AT xiaomengmeng abetteroverallsurvivalosfortotalipsilateralretroperitoneallipectomythanstandardcompleteresectioninpatientswithretroperitonealliposarcomaacomparativemultiinstitutionalstudy AT chalichao abetteroverallsurvivalosfortotalipsilateralretroperitoneallipectomythanstandardcompleteresectioninpatientswithretroperitonealliposarcomaacomparativemultiinstitutionalstudy AT wangjiongyuan abetteroverallsurvivalosfortotalipsilateralretroperitoneallipectomythanstandardcompleteresectioninpatientswithretroperitonealliposarcomaacomparativemultiinstitutionalstudy AT renyubo abetteroverallsurvivalosfortotalipsilateralretroperitoneallipectomythanstandardcompleteresectioninpatientswithretroperitonealliposarcomaacomparativemultiinstitutionalstudy AT yanghaoyun abetteroverallsurvivalosfortotalipsilateralretroperitoneallipectomythanstandardcompleteresectioninpatientswithretroperitonealliposarcomaacomparativemultiinstitutionalstudy AT luochenghua abetteroverallsurvivalosfortotalipsilateralretroperitoneallipectomythanstandardcompleteresectioninpatientswithretroperitonealliposarcomaacomparativemultiinstitutionalstudy AT miaochengli betteroverallsurvivalosfortotalipsilateralretroperitoneallipectomythanstandardcompleteresectioninpatientswithretroperitonealliposarcomaacomparativemultiinstitutionalstudy AT zhanglingling betteroverallsurvivalosfortotalipsilateralretroperitoneallipectomythanstandardcompleteresectioninpatientswithretroperitonealliposarcomaacomparativemultiinstitutionalstudy AT tsengwilliamw betteroverallsurvivalosfortotalipsilateralretroperitoneallipectomythanstandardcompleteresectioninpatientswithretroperitonealliposarcomaacomparativemultiinstitutionalstudy AT qiufabo betteroverallsurvivalosfortotalipsilateralretroperitoneallipectomythanstandardcompleteresectioninpatientswithretroperitonealliposarcomaacomparativemultiinstitutionalstudy AT luweiqi betteroverallsurvivalosfortotalipsilateralretroperitoneallipectomythanstandardcompleteresectioninpatientswithretroperitonealliposarcomaacomparativemultiinstitutionalstudy AT daiyouguo betteroverallsurvivalosfortotalipsilateralretroperitoneallipectomythanstandardcompleteresectioninpatientswithretroperitonealliposarcomaacomparativemultiinstitutionalstudy AT raoxiaosong betteroverallsurvivalosfortotalipsilateralretroperitoneallipectomythanstandardcompleteresectioninpatientswithretroperitonealliposarcomaacomparativemultiinstitutionalstudy AT liwenjie betteroverallsurvivalosfortotalipsilateralretroperitoneallipectomythanstandardcompleteresectioninpatientswithretroperitonealliposarcomaacomparativemultiinstitutionalstudy AT zhanggaokui betteroverallsurvivalosfortotalipsilateralretroperitoneallipectomythanstandardcompleteresectioninpatientswithretroperitonealliposarcomaacomparativemultiinstitutionalstudy AT chenjun betteroverallsurvivalosfortotalipsilateralretroperitoneallipectomythanstandardcompleteresectioninpatientswithretroperitonealliposarcomaacomparativemultiinstitutionalstudy AT liuwenqing betteroverallsurvivalosfortotalipsilateralretroperitoneallipectomythanstandardcompleteresectioninpatientswithretroperitonealliposarcomaacomparativemultiinstitutionalstudy AT chenxiaobing betteroverallsurvivalosfortotalipsilateralretroperitoneallipectomythanstandardcompleteresectioninpatientswithretroperitonealliposarcomaacomparativemultiinstitutionalstudy AT xiaomengmeng betteroverallsurvivalosfortotalipsilateralretroperitoneallipectomythanstandardcompleteresectioninpatientswithretroperitonealliposarcomaacomparativemultiinstitutionalstudy AT chalichao betteroverallsurvivalosfortotalipsilateralretroperitoneallipectomythanstandardcompleteresectioninpatientswithretroperitonealliposarcomaacomparativemultiinstitutionalstudy AT wangjiongyuan betteroverallsurvivalosfortotalipsilateralretroperitoneallipectomythanstandardcompleteresectioninpatientswithretroperitonealliposarcomaacomparativemultiinstitutionalstudy AT renyubo betteroverallsurvivalosfortotalipsilateralretroperitoneallipectomythanstandardcompleteresectioninpatientswithretroperitonealliposarcomaacomparativemultiinstitutionalstudy AT yanghaoyun betteroverallsurvivalosfortotalipsilateralretroperitoneallipectomythanstandardcompleteresectioninpatientswithretroperitonealliposarcomaacomparativemultiinstitutionalstudy AT luochenghua betteroverallsurvivalosfortotalipsilateralretroperitoneallipectomythanstandardcompleteresectioninpatientswithretroperitonealliposarcomaacomparativemultiinstitutionalstudy |